Standardization of PD-L1 immunohistochemistry

por Martinez-Morilla, Sandra, Moutafi, Myrto, Rimm, David L.
Publicado 2021

Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma

por Palamaris, Kostas, Moutafi, Myrto, Gakiopoulou, Hariklia, Theocharis, Stamatios
Publicado 2022

The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic Review

por Korakiti, Anna-Maria, Moutafi, Myrto, Zografos, Eleni, Dimopoulos, Meletios-Athanasios, Zagouri, Flora
Publicado 2020

A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options

por Moutafi, Myrto, Ziogas, Dimitrios C., Michopoulos, Spyros, Bagratuni, Tina, Vasileiou, Vassiliki, Verga, Laura, Merlini, Giampaolo, Palladini, Giovanni, Matsouka, Charis, Dimopoulos, Meletios A., Kastritis, Efstathios
Publicado 2019

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance

por Schoenfeld, David A., Merkin, Ross D., Moutafi, Myrto, Martinez, Sandra, Adeniran, Adebowale, Kumar, Deepika, Jilaveanu, Lucia, Hurwitz, Michael, Rimm, David L., Kluger, Harriet M.
Publicado 2022

Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy

por Martinez-Morilla, Sandra, Moutafi, Myrto, Fernandez, Aileen I., Jessel, Shlomit, Divakar, Prajan, Wong, Pok Fai, Garcia-Milian, Rolando, Schalper, Kurt A., Kluger, Harriet M., Rimm, David L.
Publicado 2023

Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

por Moutafi, Myrto K, Tao, Weiwei, Huang, Richard, Haberberger, James, Alexander, Brian, Ramkissoon, Shakti, Ross, Jeffrey S, Syrigos, Konstantinos, Wei, Wei, Pusztai, Lajos, Rimm, David L, Vathiotis, Ioannis A
Publicado 2021

Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma

por Gavrielatou, Niki, Vathiotis, Ioannis, Aung, Thazin Nwe, Shafi, Saba, Burela, Sneha, Fernandez, Aileen I., Moutafi, Myrto, Burtness, Barbara, Economopoulou, Panagiota, Anastasiou, Maria, Foukas, Periklis, Psyrri, Amanda, Rimm, David L.
Publicado 2023

Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control study

por Yaghoobi, Vesal, Moutafi, Myrto, Aung, Thazin Nwe, Pelekanou, Vasiliki, Yaghoubi, Sanam, Blenman, Kim, Ibrahim, Eiman, Vathiotis, Ioannis A., Shafi, Saba, Sharma, Anup, O’Meara, Tess, Fernandez, Aileen I., Pusztai, Lajos, Rimm, David L.
Publicado 2021

Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases

por Schoenfeld, David A, Moutafi, Myrto, Martinez, Sandra, Djureinovic, Dijana, Merkin, Ross D, Adeniran, Adebowale, Braun, David A, Signoretti, Sabina, Choueiri, Toni K, Parisi, Fabio, Hurwitz, Michael, Rimm, David L, Wei, Wei, Jilaveanu, Lucia, Kluger, Harriet M
Publicado 2023

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

por Aung, Thazin Nwe, Shafi, Saba, Wilmott, James S., Nourmohammadi, Saeed, Vathiotis, Ioannis, Gavrielatou, Niki, Fernandez, Aileen, Yaghoobi, Vesal, Sinnberg, Tobias, Amaral, Teresa, Ikenberg, Kristian, Khosrotehrani, Kiarash, Osman, Iman, Acs, Balazs, Bai, Yalai, Martinez-Morilla, Sandra, Moutafi, Myrto, Thompson, John F., Scolyer, Richard A., Rimm, David L.
Publicado 2022

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

por Moutafi, Myrto K, Molero, Magdalena, Martinez Morilla, Sandra, Baena, Javier, Vathiotis, Ioannis A, Gavrielatou, Niki, Castro-Labrador, Laura, de Garibay, Gorka Ruiz, Adradas, Vera, Orive, Daniel, Valencia, Karmele, Calvo, Alfonso, Montuenga, Luis M, Ponce Aix, S, Schalper, Kurt A, Herbst, Roy S, Paz-Ares, Luis, Rimm, David L, Zugazagoitia, Jon
Publicado 2022

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better

por Djureinovic, Dijana, Weiss, Sarah A., Krykbaeva, Irina, Qu, Rihao, Vathiotis, Ioannis, Moutafi, Myrto, Zhang, Lin, Perdigoto, Ana L., Wei, Wei, Anderson, Gail, Damsky, William, Hurwitz, Michael, Johnson, Barbara, Schoenfeld, David, Mahajan, Amit, Hsu, Frank, Miller-Jensen, Kathryn, Kluger, Yuval, Sznol, Mario, Kaech, Susan M., Bosenberg, Marcus, Jilaveanu, Lucia B., Kluger, Harriet M.
Publicado 2023

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

por Moutafi, Myrto, Koliou, Georgia-Angeliki, Papaxoinis, George, Economopoulou, Panagiota, Kotsantis, Ioannis, Gkotzamanidou, Maria, Anastasiou, Maria, Pectasides, Dimitrios, Kyrodimos, Efthymios, Delides, Alexander, Giotakis, Evangelos, Papadimitriou, Nikolaos G., Panayiotides, Ioannis G., Perisanidis, Christos, Fernandez, Aileen I., Xirou, Vasiliki, Poulios, Christos, Gagari, Eleni, Yaghoobi, Vesal, Gavrielatou, Niki, Shafi, Saba, Aung, Thazin Nwe, Kougioumtzopoulou, Andromachi, Kouloulias, Vassilis, Palialexis, Konstantinos, Gkolfinopoulos, Stavros, Strati, Areti, Lianidou, Evi, Fountzilas, George, Rimm, David L., Foukas, Periklis G., Psyrri, Amanda
Publicado 2023